PATENT CLAIM ANALYSIS

Application Number: 15745348
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "237500"]

Abstract:
The present invention relates to a novel compound showing leukotriene B4 receptor 2 (BLT2) inhibitory activity and a pharmaceutical composition, for preventing or treating inflammatory diseases, having same as an active ingredient. The inventors identified a novel compound containing BTL2 inhibitory activity, and experimentally confirmed that the present novel compound had an excellent effect on the enhancement of the cancer cell death, on the inhibition of the metastasis and chemotactic mobility, and on the anti-asthma activity. Therefore, the present novel compound can be used as a very effective pharmaceutical component for treating the inflammatory-related diseases.

Claim (Index 6):
A method for preventing or treating an inflammatory disease, comprising:\n administering the compound of  claim 1 , wherein a pharmaceutically acceptable salt thereof to a subject.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.63077
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15745337', '13825989', '14317024', '14651211', '10486602']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7411470719343526
- 35 USC 102 Novelty (BERT): 0.5597814173612536
- Combined Prediction Score: 0.7230105064770427
- Mean Citation Score: 325.190902
- Max Citation Score: 430.21097
- Similarity Product: 330.5806027036917

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test